Editorial policy

What this policy covers

This policy explains how the content on this website is written, checked and corrected. It applies to every page, including the product range pages, the company pages and the legal pages.

Who writes the content

Content is written and maintained by the Aarmac Life Sciences team in Coimbatore. Product entries are compiled from our own approved pack information. No outside agency writes our product content.

What we publish

For each brand we publish three things: the brand name, the dosage form, and the composition. That is enough for a prescriber to identify a pack. We also publish company information, contact details and careers information.

What we do not publish

We do not publish patient-facing treatment advice. We do not publish dosing schedules, indications, or comparisons with other companies' products. We do not publish testimonials, reviews or case reports. We do not claim that a product is better, safer or faster than another product.

Full prescribing information belongs in the approved pack insert, not on a web page. Where this website and the pack insert differ, the pack insert is correct.

How content is checked

Before a product page goes live, the brand name, dosage form and composition are checked against our current pack information. Pages carry a "last updated" date. When a formulation, a pack size or a brand name changes, the page is updated and the date changes with it.

Corrections

If you find something on this site that is wrong or out of date, tell us. Email aarmaclifesciences26@gmail.com with the page address and what is wrong. We will check it against our records and correct the page if it is wrong.

Advertising and sponsorship

This website carries no advertising. No third party pays to appear on it. There are no affiliate links. Nothing on this site is placed in exchange for payment.

Adverse event reporting

This site is not a substitute for pharmacovigilance reporting. Healthcare professionals who observe a suspected adverse reaction should email us with the brand name, the batch number and a description, and may also report it to the Pharmacovigilance Programme of India run by the Indian Pharmacopoeia Commission.

Changes to this policy

If this policy changes, the new version appears on this page with a new date at the top.